These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24314511)

  • 1. Estimating daily and diurnal variations of illicit drug use in Hong Kong: a pilot study of using wastewater analysis in an Asian metropolitan city.
    Lai FY; Bruno R; Leung HW; Thai PK; Ort C; Carter S; Thompson K; Lam PK; Mueller JF
    Forensic Sci Int; 2013 Dec; 233(1-3):126-32. PubMed ID: 24314511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring.
    González-Mariño I; Baz-Lomba JA; Alygizakis NA; Andrés-Costa MJ; Bade R; Bannwarth A; Barron LP; Been F; Benaglia L; Berset JD; Bijlsma L; Bodík I; Brenner A; Brock AL; Burgard DA; Castrignanò E; Celma A; Christophoridis CE; Covaci A; Delémont O; de Voogt P; Devault DA; Dias MJ; Emke E; Esseiva P; Fatta-Kassinos D; Fedorova G; Fytianos K; Gerber C; Grabic R; Gracia-Lor E; Grüner S; Gunnar T; Hapeshi E; Heath E; Helm B; Hernández F; Kankaanpaa A; Karolak S; Kasprzyk-Hordern B; Krizman-Matasic I; Lai FY; Lechowicz W; Lopes A; López de Alda M; López-García E; Löve ASC; Mastroianni N; McEneff GL; Montes R; Munro K; Nefau T; Oberacher H; O'Brien JW; Oertel R; Olafsdottir K; Picó Y; Plósz BG; Polesel F; Postigo C; Quintana JB; Ramin P; Reid MJ; Rice J; Rodil R; Salgueiro-González N; Schubert S; Senta I; Simões SM; Sremacki MM; Styszko K; Terzic S; Thomaidis NS; Thomas KV; Tscharke BJ; Udrisard R; van Nuijs ALN; Yargeau V; Zuccato E; Castiglioni S; Ort C
    Addiction; 2020 Jan; 115(1):109-120. PubMed ID: 31642141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illicit drug consumption estimated using wastewater analysis and compared by settlement size in New Zealand.
    Chappell A; Armstrong B; Jay E; Phung K; McCormick S; Grigg S; Waite B
    Sci Total Environ; 2022 Oct; 843():156956. PubMed ID: 35760179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spatial epidemiology of cocaine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater.
    Banta-Green CJ; Field JA; Chiaia AC; Sudakin DL; Power L; de Montigny L
    Addiction; 2009 Nov; 104(11):1874-80. PubMed ID: 19624572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial, temporal and socioeconomic patterns of illicit drug use in New Zealand assessed using wastewater-based epidemiology timed to coincide with the census.
    Price M; Wilkins C; Tscharke BJ; Baker T; Mueller JF; Trowsdale S
    N Z Med J; 2021 Jun; 134(1537):11-26. PubMed ID: 34239158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consumption of common illicit drugs in twenty-one cities in southwest China through wastewater analysis.
    Wang H; Xu B; Yang L; Huo T; Bai D; An Q; Li X
    Sci Total Environ; 2022 Dec; 851(Pt 1):158105. PubMed ID: 35987225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine, MDMA and methamphetamine residues in wastewater: Consumption trends (2009-2015) in South East Queensland, Australia.
    Lai FY; O'Brien JW; Thai PK; Hall W; Chan G; Bruno R; Ort C; Prichard J; Carter S; Anuj S; Kirkbride KP; Gartner C; Humphries M; Mueller JF
    Sci Total Environ; 2016 Oct; 568():803-809. PubMed ID: 27325011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis.
    Chen C; Kostakis C; Harpas P; Felgate PD; Irvine RJ; White JM
    J Stud Alcohol Drugs; 2011 Sep; 72(5):737-40. PubMed ID: 21906501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population drug use in Australia: a wastewater analysis.
    Irvine RJ; Kostakis C; Felgate PD; Jaehne EJ; Chen C; White JM
    Forensic Sci Int; 2011 Jul; 210(1-3):69-73. PubMed ID: 21388761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessing illicit drugs in wastewater: a pilot study in Mexico].
    Cruz-Cruz C; Vidaña-Pérez D; Mondragón Y Kalb M; Martínez-Ruiz MJ; Olaiz-Fernández G; Hernández-Lezama LF; Hernández-Ávila M; Barrientos-Gutiérrez T
    Salud Publica Mex; 2019; 61(4):461-469. PubMed ID: 31314209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial variations in the consumption of illicit stimulant drugs across Australia: A nationwide application of wastewater-based epidemiology.
    Lai FY; O'Brien J; Bruno R; Hall W; Prichard J; Kirkbride P; Gartner C; Thai P; Carter S; Lloyd B; Burns L; Mueller J
    Sci Total Environ; 2016 Oct; 568():810-818. PubMed ID: 27267725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illicit drug consumption in school populations measured by wastewater analysis.
    Zuccato E; Gracia-Lor E; Rousis NI; Parabiaghi A; Senta I; Riva F; Castiglioni S
    Drug Alcohol Depend; 2017 Sep; 178():285-290. PubMed ID: 28686986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of spatial and temporal changes in illicit drug use in the Taipei metropolitan area via wastewater-based epidemiology.
    Lin HH; Wang YH; Liu JIWW; Hsieh MC; Huang SJ; Lien E; Huang LW; Lin AY
    Sci Total Environ; 2024 Jul; 934():173313. PubMed ID: 38761952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis.
    Ort C; van Nuijs AL; Berset JD; Bijlsma L; Castiglioni S; Covaci A; de Voogt P; Emke E; Fatta-Kassinos D; Griffiths P; Hernández F; González-Mariño I; Grabic R; Kasprzyk-Hordern B; Mastroianni N; Meierjohann A; Nefau T; Ostman M; Pico Y; Racamonde I; Reid M; Slobodnik J; Terzic S; Thomaidis N; Thomas KV
    Addiction; 2014 Aug; 109(8):1338-52. PubMed ID: 24861844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wastewater-based monitoring of illicit drugs in Cyprus by UPLC-MS/MS: The impact of the COVID-19 pandemic.
    Psichoudaki M; Mina T; Savvidou M; Mina C; Michael C; Fatta-Kassinos D
    Sci Total Environ; 2023 Jan; 854():158747. PubMed ID: 36108831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs of abuse in wastewater and suspended particulate matter--further developments in sewage epidemiology.
    Baker DR; Očenášková V; Kvicalova M; Kasprzyk-Hordern B
    Environ Int; 2012 Nov; 48():28-38. PubMed ID: 22832187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of trends in wastewater-based data and traditional epidemiological indicators of stimulant consumption in three locations.
    Goulding N; Hickman M; Reid M; Amundsen EJ; Baz-Lomba JA; O'Brien JW; Tscharke BJ; de Voogt P; Emke E; Kuijpers W; Hall W; Jones HE
    Addiction; 2020 Mar; 115(3):462-472. PubMed ID: 31633843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illicit drugs in Canadian municipal wastewater and estimates of community drug use.
    Metcalfe C; Tindale K; Li H; Rodayan A; Yargeau V
    Environ Pollut; 2010 Oct; 158(10):3179-85. PubMed ID: 20667638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment.
    Lai FY; Ort C; Gartner C; Carter S; Prichard J; Kirkbride P; Bruno R; Hall W; Eaglesham G; Mueller JF
    Water Res; 2011 Oct; 45(15):4437-48. PubMed ID: 21745676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first application of wastewater-based drug epidemiology in five South Korean cities.
    Kim KY; Lai FY; Kim HY; Thai PK; Mueller JF; Oh JE
    Sci Total Environ; 2015 Aug; 524-525():440-6. PubMed ID: 25933175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.